Search - tctmd.com

Displaying 201 - 220 of 264

Sort: Relevancy | Date

News Conference News TCT 2012

Meta-Analyses Show Improved Outcomes with DES vs. BMS

October 22, 2012

News Conference News TCT 2012

COURAGE, FAME: Revascularization More Effective Than OMT

October 22, 2012

News Industry News

Analysis Of Medtronic Stent Finds Early Cessation Of Dual Antiplatelet Therapy Caused No Increased Risk Of Blood Clots To One Year

October 22, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

News Daily News

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

Yael L. Maxwell

September 07, 2012

News Daily News

SORT OUT IV: El Xience Aguanta el Tirón del Cypher en la Prevención de la Trombosis del Stent

Yael L. Maxwell

September 07, 2012

News Industry News

Medtronic Launches Resolute Integrity Coronary Stent System in Japan

August 28, 2012

News Conference News ESC 2012

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

August 27, 2012

News Conference News ESC 2012

PCI Fails to Match CABG in Diabetic Patients with Multivessel Disease

Yael L. Maxwell

August 27, 2012

News Daily News

SORT OUT III: Riesgo más alto de trombosis del stent muy tardía con Cypher en comparación con Endeavor

L.A. McKeown

August 23, 2012

News Daily News

SORT OUT III: Higher Risk of Very Late Stent Thrombosis with Cypher vs. Endeavor

L.A. McKeown

August 23, 2012

News Daily News

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Leah Lawrence

June 15, 2012

News Daily News

Meta Análisis: Menor Trombosis del Stent a los 2 Años con SLE que con Otro Tipo de SLF

Leah Lawrence

June 15, 2012

News Industry News

STENTYS starts clinical trial to broaden portfolio with new drug-eluting stent

June 14, 2012

News Industry News

Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes

May 25, 2012

News Daily News

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

May 22, 2012

News Daily News

Meta Análisis: Superior Eficacia de los SLF sin poner en Peligro la Seguridad

May 22, 2012

Presentation EuroPCR 2012

Three-year Outcomes from the Randomized Comparison of a Zotarolimus-eluting and an Everolimus-eluting Stent in the RESOLUTE All Comers Trial

Presenter: Stephan Windecker

May 16, 2012

News Industry News

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

May 15, 2012

Advertisement

Meta-Analyses Show Improved Outcomes with DES vs. BMS

COURAGE, FAME: Revascularization More Effective Than OMT

Analysis Of Medtronic Stent Finds Early Cessation Of Dual Antiplatelet Therapy Caused No Increased Risk Of Blood Clots To One Year

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

SORT OUT IV: El Xience Aguanta el Tirón del Cypher en la Prevención de la Trombosis del Stent

Medtronic Launches Resolute Integrity Coronary Stent System in Japan

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

PCI Fails to Match CABG in Diabetic Patients with Multivessel Disease

SORT OUT III: Riesgo más alto de trombosis del stent muy tardía con Cypher en comparación con Endeavor

SORT OUT III: Higher Risk of Very Late Stent Thrombosis with Cypher vs. Endeavor

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Meta Análisis: Menor Trombosis del Stent a los 2 Años con SLE que con Otro Tipo de SLF

STENTYS starts clinical trial to broaden portfolio with new drug-eluting stent

Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

Meta Análisis: Superior Eficacia de los SLF sin poner en Peligro la Seguridad

Three-year Outcomes from the Randomized Comparison of a Zotarolimus-eluting and an Everolimus-eluting Stent in the RESOLUTE All Comers Trial

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content